Exoskeleton Market Growth, Size, Trends Analysis - By Mobility, By Technology, By Extremity, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Exoskeleton Market Introduction and Overview

According to SPER Market Research, 'Global Exoskeleton Market Size - By Mobility, By Technology, By Extremity, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Exoskeleton Market is predicted to reach 2326.2 million by 2034 with a CAGR of 16.85%.

Exoskeletons are robotic-assisted wearable devices that enhance human mobility, strength, and endurance by providing external support to the body. These systems are used in healthcare to assist individuals with paralysis or musculoskeletal disorders, enabling rehabilitation and improving quality of life. In industrial settings, exoskeletons help reduce physical strain on workers, preventing injuries and improving productivity.

Restraints: Exoskeletons have great potential, but a number of obstacles prevent their widespread use. Many people and organizations, especially in developing nations, cannot afford these devices due to their high manufacture and purchase prices. Long-term usage and user comfort are impacted by exoskeleton weight and battery restrictions. Long approval procedures and regulatory barriers prevent new items from entering the market quickly, which limits innovation.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Mobility, By Technology, By Extremity, By End Use

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

ActiveLink, Cyberdyne Inc, Ekso Bionics, Hocoma, Lockheed Martin Corporation, RB3D, ReWalk Robotics, Rex Bionics Plc, Suit X

Global Exoskeleton Market Segmentation:

By Mobility: Based on the Mobility, Global Exoskeleton Market is segmented as; Mobile and Fixed/Stationary.

By Technology: Based on the Technology, Global Exoskeleton Market is segmented as; Powered and Non-Powered.

By Extremity: Based on the Extremity, Global Exoskeleton Market is segmented as; Upper Body, Lower Body and Full Body.

By End Use: Based on the End Use, Global Exoskeleton Market is segmented as; Healthcare, Military and Industry.

Product Code: HLCA25102

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Exoskeleton Market Manufacturing Base Distribution, Sales Area, Interface Type
6.2. Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Exoskeleton Market

7. Global Exoskeleton Market, By Mobility 2021-2034 (USD Million)

7.1. Mobile
7.2. Fixed/Stationary

8. Global Exoskeleton Market, By Technology 2021-2034 (USD Million)

8.1. Powered
8.2. Non-Powered

9. Global Exoskeleton Market, By Extremity 2021-2034 (USD Million)

9.1. Upper Body
9.2. Lower Body
9.3. Full Body

10. Global Exoskeleton Market, By End Use 2021-2034 (USD Million)

10.1. Healthcare
10.2. Military
10.3. Industry

11. Global Exoskeleton Market, 2021-2034 (USD Million)

11.1. Global Exoskeleton Market Size and Market Share

12. Global Exoskeleton Market, By Region, 2021-2034 (USD Million)

12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America

13. Company Profile

13.1. ActiveLink
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Interface summary
- 13.1.4. Recent developments
13.2. Cyberdyne Inc
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Interface summary
- 13.2.4. Recent developments
13.3. Ekso Bionics
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Interface summary
- 13.3.4. Recent developments
13.4. Hocoma
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Interface summary
- 13.4.4. Recent developments
13.5. Lockheed Martin Corporation
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Interface summary
- 13.5.4. Recent developments
13.6. RB3D
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Interface summary
- 13.6.4. Recent developments
13.7. ReWalk Robotics
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Interface summary
- 13.7.4. Recent developments
13.8. Rex Bionics Plc
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Interface summary
- 13.8.4. Recent developments
13.9. Suit X
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Interface summary
- 13.9.4. Recent developments